Loading insider details...
Latest Form 4 (May 21, 2026): Grant/Award of 24,122 PHAT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 24,122 | n/a |
| Jan 8, 2026 | Cidara Therapeutics, Inc. (CDTX) | Disposition to Issuer | 450 | n/a |
| Jun 18, 2025 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 11,100 | n/a |
| Apr 16, 2025 | Phathom Pharmaceuticals, Inc. (PHAT) | Grant/Award | 21,000 | n/a |
| Dec 19, 2024 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 20,500 | n/a |
| Jul 19, 2024 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 2,125 | n/a |
| Jun 23, 2023 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 42,500 | n/a |
| Jun 24, 2022 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 28,000 | n/a |
| Jun 24, 2021 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 17,500 | n/a |
| Jun 25, 2020 | Cidara Therapeutics, Inc. (CDTX) | Grant/Award | 17,500 | n/a |